FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1771683 · Received July 27, 2010

Report

Report Number
2134265-2010-03335
Event Type
Injury
Date Received
July 27, 2010
Date of Event
June 28, 2010
Report Date
June 29, 2010
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT . DEVICE EVALUATED BY MANUFACTURER- IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

SAME CASE AS MFR# 2134265-2010-03448. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, THROMBOSIS OCCURRED AND THE PATIENT HAD AN STEMI. THE PATIENT PRESENTED TO THE CATH LAB WITH CHEST PAIN THAT RADIATED TO THE LEFT ARM AND AN INFERIOR WALL MYOCARDIAL INFARCTION (MI). ACCESS WAS OBTAINED THROUGH THE RIGHT FEMORAL ARTERY. THE 60-70% STENOSED TARGET LESION WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). THE MID RCA HAD A PREVIOUSLY IMPLANTED STENT WHICH WAS PATENT, HOWEVER AN ADDITIONAL 40-50% TARGET LESION WAS LOCATED IN THE DISTAL RCA. A JR 4.0 GUIDECATHETER ENGAGED WITH VESSEL AND A NON-BSC GUIDEWIRE WAS ADVANCED. NEXT, A 2.25X16MM TAXUS LIBERTE STENT DELIVERY SYSTEM (SDS) WAS ADVANCED TO THE DISTAL RCA WHERE THERE WAS IN-STENT STENOSIS FROM A PREVIOUS STENT. THE TAXUS LIBERTE STENT WAS DEPLOYED AT 13ATMS AND POST DILATED WITH LOW PRESSURE INFLATIONS TO 4ATMS. ANGIOGRAPHY REVEALED TIMI 3 FLOW. NEXT, A TAXUS 2.5X12MM SDS WAS ADVANCED TO THE PROXIMAL RCA AND THE STENT WAS DEPLOYED TO 14ATMS AND WAS POST DILATED TO 15ATMS. ADDITIONAL LOW PRESSURE INFLATIONS TO 5 ATMS WERE PERFORMED. ANGIOGRAM REVEALED TIMI 3 FLOW WITH 0% STENOSIS. THE PATIENT WAS PLACED ON ECOTRIN AND PLAVIX AND WILL RESUME TAKING LIPITOR. FOURTEEN DAYS LATER, THE PATIENT HAD A ST ELEVATED INFERIOR WALL MYOCARDIAL INFARCTION (STEMI) AND WAS ADMINISTERED TNKASE. IT WAS NOTED THAT THE PATIENT WAS NONCOMPLIANT AND STOPPED TAKING PLAVIX. TWO DAYS AFTER THE MI, A CARDIAC CATHETERIZATION REVEALED THAT THE DISTAL RCA HAD 95% LUMINAL NARROWING AND THE ARTERY WAS SIGNIFICANTLY SMALL EXCEPT WHERE IT HAD BEEN PREVIOUSLY STENTED. INTRACORONARY INJECTION OF 100MCG OF NITRO WAS GIVEN AND THE 95% NARROWING IN THE DISTAL RCA RESOLVED AND THE SIZE OF THE ARTERY IMPROVED. THE AREA OF THE STENTS DID NOT HAVE SIGNIFICANT STENOSIS OR THROMBUS HOWEVER PER THE PHYSICIAN THE MI WAS DUE TO A COMBINATION OF THE SPASM AND POTENTIAL ACUTE IN-STENT THROMBOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893616220

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization| R PROWATER GUIDEWIRE| TAXUS 2.5X12| JR 4.0 GUIDE CATHETER